Personalized versus standard cognitive behavioral therapy for fear of cancer recurrence, depressive symptoms or cancer-related fatigue in cancer survivors: study protocol of a randomized controlled trial (MATCH-study)

Abstract Background Fear of cancer recurrence, depressive symptoms, and cancer-related fatigue are prevalent symptoms among cancer survivors, adversely affecting patients’ quality of life and daily functioning. Effect sizes of interventions targeting these symptoms are mostly small to medium. Person...

Full description

Bibliographic Details
Main Authors: Susan J. Harnas, Hans Knoop, Floor Bennebroek Evertsz, Sanne H. Booij, Joost Dekker, Hanneke W. M. van Laarhoven, Marije van der Lee, Ellen Meijer, Louise Sharpe, Mirjam A. G. Sprangers, Annemieke van Straten, Sonja Zweegman, Annemarie M. J. Braamse
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Trials
Subjects:
Online Access:https://doi.org/10.1186/s13063-021-05657-z
_version_ 1819112455025983488
author Susan J. Harnas
Hans Knoop
Floor Bennebroek Evertsz
Sanne H. Booij
Joost Dekker
Hanneke W. M. van Laarhoven
Marije van der Lee
Ellen Meijer
Louise Sharpe
Mirjam A. G. Sprangers
Annemieke van Straten
Sonja Zweegman
Annemarie M. J. Braamse
author_facet Susan J. Harnas
Hans Knoop
Floor Bennebroek Evertsz
Sanne H. Booij
Joost Dekker
Hanneke W. M. van Laarhoven
Marije van der Lee
Ellen Meijer
Louise Sharpe
Mirjam A. G. Sprangers
Annemieke van Straten
Sonja Zweegman
Annemarie M. J. Braamse
author_sort Susan J. Harnas
collection DOAJ
description Abstract Background Fear of cancer recurrence, depressive symptoms, and cancer-related fatigue are prevalent symptoms among cancer survivors, adversely affecting patients’ quality of life and daily functioning. Effect sizes of interventions targeting these symptoms are mostly small to medium. Personalizing treatment is assumed to improve efficacy. However, thus far the empirical support for this approach is lacking. The aim of this study is to investigate if systematically personalized cognitive behavioral therapy is more efficacious than standard cognitive behavioral therapy in cancer survivors with moderate to severe fear of cancer recurrence, depressive symptoms, and/or cancer-related fatigue. Methods The study is designed as a non-blinded, multicenter randomized controlled trial with two treatment arms (ratio 1:1): (a) systematically personalized cognitive behavioral therapy and (b) standard cognitive behavioral therapy. In the standard treatment arm, patients receive an evidence-based diagnosis-specific treatment protocol for fear of cancer recurrence, depressive symptoms, or cancer-related fatigue. In the second arm, treatment is personalized on four dimensions: (a) the allocation of treatment modules based on ecological momentary assessments, (b) treatment delivery, (c) patients’ needs regarding the symptom for which they want to receive treatment, and (d) treatment duration. In total, 190 cancer survivors who experience one or more of the targeted symptoms and ended their medical treatment with curative intent at least 6 months to a maximum of 5 years ago will be included. Primary outcome is limitations in daily functioning. Secondary outcomes are level of fear of cancer recurrence, depressive symptoms, fatigue severity, quality of life, goal attainment, therapist time, and drop-out rates. Participants are assessed at baseline (T0), and after 6 months (T1) and 12 months (T2). Discussion To our knowledge, this is the first randomized controlled trial comparing the efficacy of personalized cognitive behavioral therapy to standard cognitive behavioral therapy in cancer survivors. The study has several innovative characteristics, among which is the personalization of interventions on several dimensions. If proven effective, the results of this study provide a first step in developing an evidence-based framework for personalizing therapies in a systematic and replicable way. Trial registration The Dutch Trial Register (NTR) NL7481 (NTR7723). Registered on 24 January 2019.
first_indexed 2024-12-22T04:13:46Z
format Article
id doaj.art-3928e6b4f9064934998c2f5251917a35
institution Directory Open Access Journal
issn 1745-6215
language English
last_indexed 2024-12-22T04:13:46Z
publishDate 2021-10-01
publisher BMC
record_format Article
series Trials
spelling doaj.art-3928e6b4f9064934998c2f5251917a352022-12-21T18:39:27ZengBMCTrials1745-62152021-10-0122111610.1186/s13063-021-05657-zPersonalized versus standard cognitive behavioral therapy for fear of cancer recurrence, depressive symptoms or cancer-related fatigue in cancer survivors: study protocol of a randomized controlled trial (MATCH-study)Susan J. Harnas0Hans Knoop1Floor Bennebroek Evertsz2Sanne H. Booij3Joost Dekker4Hanneke W. M. van Laarhoven5Marije van der Lee6Ellen Meijer7Louise Sharpe8Mirjam A. G. Sprangers9Annemieke van Straten10Sonja Zweegman11Annemarie M. J. Braamse12Department of Medical Psychology, Cancer Center Amsterdam, Amsterdam Public Health Research Institute, Amsterdam UMC, University of AmsterdamDepartment of Medical Psychology, Cancer Center Amsterdam, Amsterdam Public Health Research Institute, Amsterdam UMC, University of AmsterdamDepartment of Medical Psychology, Amsterdam Public Health Research Institute, Amsterdam UMC, University of AmsterdamDepartment of Developmental Psychology, Faculty of Behavioural and Social Sciences, University of GroningenDepartment of Psychiatry, Cancer Center Amsterdam, Amsterdam Public Health Research Institute, Amsterdam UMC, VU UniversityDepartment of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of AmsterdamResearch Department, Center for Psycho-Oncology, Helen Dowling InstituteDepartment of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit AmsterdamSchool of Psychology, Faculty of Science, University of SydneyDepartment of Medical Psychology, Cancer Center Amsterdam, Amsterdam Public Health Research Institute, Amsterdam UMC, University of AmsterdamDepartment of Clinical, Neuro and Developmental Psychology & Amsterdam Public Health Research Institute, VU UniversityDepartment of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit AmsterdamDepartment of Medical Psychology, Cancer Center Amsterdam, Amsterdam Public Health Research Institute, Amsterdam UMC, University of AmsterdamAbstract Background Fear of cancer recurrence, depressive symptoms, and cancer-related fatigue are prevalent symptoms among cancer survivors, adversely affecting patients’ quality of life and daily functioning. Effect sizes of interventions targeting these symptoms are mostly small to medium. Personalizing treatment is assumed to improve efficacy. However, thus far the empirical support for this approach is lacking. The aim of this study is to investigate if systematically personalized cognitive behavioral therapy is more efficacious than standard cognitive behavioral therapy in cancer survivors with moderate to severe fear of cancer recurrence, depressive symptoms, and/or cancer-related fatigue. Methods The study is designed as a non-blinded, multicenter randomized controlled trial with two treatment arms (ratio 1:1): (a) systematically personalized cognitive behavioral therapy and (b) standard cognitive behavioral therapy. In the standard treatment arm, patients receive an evidence-based diagnosis-specific treatment protocol for fear of cancer recurrence, depressive symptoms, or cancer-related fatigue. In the second arm, treatment is personalized on four dimensions: (a) the allocation of treatment modules based on ecological momentary assessments, (b) treatment delivery, (c) patients’ needs regarding the symptom for which they want to receive treatment, and (d) treatment duration. In total, 190 cancer survivors who experience one or more of the targeted symptoms and ended their medical treatment with curative intent at least 6 months to a maximum of 5 years ago will be included. Primary outcome is limitations in daily functioning. Secondary outcomes are level of fear of cancer recurrence, depressive symptoms, fatigue severity, quality of life, goal attainment, therapist time, and drop-out rates. Participants are assessed at baseline (T0), and after 6 months (T1) and 12 months (T2). Discussion To our knowledge, this is the first randomized controlled trial comparing the efficacy of personalized cognitive behavioral therapy to standard cognitive behavioral therapy in cancer survivors. The study has several innovative characteristics, among which is the personalization of interventions on several dimensions. If proven effective, the results of this study provide a first step in developing an evidence-based framework for personalizing therapies in a systematic and replicable way. Trial registration The Dutch Trial Register (NTR) NL7481 (NTR7723). Registered on 24 January 2019.https://doi.org/10.1186/s13063-021-05657-zPsychological symptomsFear of cancer recurrenceDepressionCancer-related fatiguePersonalized treatmentCognitive behavioral therapy
spellingShingle Susan J. Harnas
Hans Knoop
Floor Bennebroek Evertsz
Sanne H. Booij
Joost Dekker
Hanneke W. M. van Laarhoven
Marije van der Lee
Ellen Meijer
Louise Sharpe
Mirjam A. G. Sprangers
Annemieke van Straten
Sonja Zweegman
Annemarie M. J. Braamse
Personalized versus standard cognitive behavioral therapy for fear of cancer recurrence, depressive symptoms or cancer-related fatigue in cancer survivors: study protocol of a randomized controlled trial (MATCH-study)
Trials
Psychological symptoms
Fear of cancer recurrence
Depression
Cancer-related fatigue
Personalized treatment
Cognitive behavioral therapy
title Personalized versus standard cognitive behavioral therapy for fear of cancer recurrence, depressive symptoms or cancer-related fatigue in cancer survivors: study protocol of a randomized controlled trial (MATCH-study)
title_full Personalized versus standard cognitive behavioral therapy for fear of cancer recurrence, depressive symptoms or cancer-related fatigue in cancer survivors: study protocol of a randomized controlled trial (MATCH-study)
title_fullStr Personalized versus standard cognitive behavioral therapy for fear of cancer recurrence, depressive symptoms or cancer-related fatigue in cancer survivors: study protocol of a randomized controlled trial (MATCH-study)
title_full_unstemmed Personalized versus standard cognitive behavioral therapy for fear of cancer recurrence, depressive symptoms or cancer-related fatigue in cancer survivors: study protocol of a randomized controlled trial (MATCH-study)
title_short Personalized versus standard cognitive behavioral therapy for fear of cancer recurrence, depressive symptoms or cancer-related fatigue in cancer survivors: study protocol of a randomized controlled trial (MATCH-study)
title_sort personalized versus standard cognitive behavioral therapy for fear of cancer recurrence depressive symptoms or cancer related fatigue in cancer survivors study protocol of a randomized controlled trial match study
topic Psychological symptoms
Fear of cancer recurrence
Depression
Cancer-related fatigue
Personalized treatment
Cognitive behavioral therapy
url https://doi.org/10.1186/s13063-021-05657-z
work_keys_str_mv AT susanjharnas personalizedversusstandardcognitivebehavioraltherapyforfearofcancerrecurrencedepressivesymptomsorcancerrelatedfatigueincancersurvivorsstudyprotocolofarandomizedcontrolledtrialmatchstudy
AT hansknoop personalizedversusstandardcognitivebehavioraltherapyforfearofcancerrecurrencedepressivesymptomsorcancerrelatedfatigueincancersurvivorsstudyprotocolofarandomizedcontrolledtrialmatchstudy
AT floorbennebroekevertsz personalizedversusstandardcognitivebehavioraltherapyforfearofcancerrecurrencedepressivesymptomsorcancerrelatedfatigueincancersurvivorsstudyprotocolofarandomizedcontrolledtrialmatchstudy
AT sannehbooij personalizedversusstandardcognitivebehavioraltherapyforfearofcancerrecurrencedepressivesymptomsorcancerrelatedfatigueincancersurvivorsstudyprotocolofarandomizedcontrolledtrialmatchstudy
AT joostdekker personalizedversusstandardcognitivebehavioraltherapyforfearofcancerrecurrencedepressivesymptomsorcancerrelatedfatigueincancersurvivorsstudyprotocolofarandomizedcontrolledtrialmatchstudy
AT hannekewmvanlaarhoven personalizedversusstandardcognitivebehavioraltherapyforfearofcancerrecurrencedepressivesymptomsorcancerrelatedfatigueincancersurvivorsstudyprotocolofarandomizedcontrolledtrialmatchstudy
AT marijevanderlee personalizedversusstandardcognitivebehavioraltherapyforfearofcancerrecurrencedepressivesymptomsorcancerrelatedfatigueincancersurvivorsstudyprotocolofarandomizedcontrolledtrialmatchstudy
AT ellenmeijer personalizedversusstandardcognitivebehavioraltherapyforfearofcancerrecurrencedepressivesymptomsorcancerrelatedfatigueincancersurvivorsstudyprotocolofarandomizedcontrolledtrialmatchstudy
AT louisesharpe personalizedversusstandardcognitivebehavioraltherapyforfearofcancerrecurrencedepressivesymptomsorcancerrelatedfatigueincancersurvivorsstudyprotocolofarandomizedcontrolledtrialmatchstudy
AT mirjamagsprangers personalizedversusstandardcognitivebehavioraltherapyforfearofcancerrecurrencedepressivesymptomsorcancerrelatedfatigueincancersurvivorsstudyprotocolofarandomizedcontrolledtrialmatchstudy
AT annemiekevanstraten personalizedversusstandardcognitivebehavioraltherapyforfearofcancerrecurrencedepressivesymptomsorcancerrelatedfatigueincancersurvivorsstudyprotocolofarandomizedcontrolledtrialmatchstudy
AT sonjazweegman personalizedversusstandardcognitivebehavioraltherapyforfearofcancerrecurrencedepressivesymptomsorcancerrelatedfatigueincancersurvivorsstudyprotocolofarandomizedcontrolledtrialmatchstudy
AT annemariemjbraamse personalizedversusstandardcognitivebehavioraltherapyforfearofcancerrecurrencedepressivesymptomsorcancerrelatedfatigueincancersurvivorsstudyprotocolofarandomizedcontrolledtrialmatchstudy